PolyNovo
Update in progressPNV.AX (ASX)
- Company RatingNeutralCompany RatingCombines sentiment and sustainability signals into an overall assessment of the company.Great · Good · Neutral · At Risk · Poor
- SectorHealthcare
- IndustryMedical Devices
PolyNovo Limited designs, manufactures, and sells biodegradable medical devices. Based in Port Melbourne, Australia, it operates in Australia, New Zealand, the United States, the United Kingdom, Ireland, Singapore, India, and Hong Kong. Its flagship NovoSorb Biodegradable Temporising Matrix is a dermal scaffold for regeneration after surgery, trauma, or burns. It is developing hernia devices, Beta Cell implant for type 1 diabetes, NovoSorb MTX for single-stage grafting, and other reconstructive products. Formerly Calzada Limited, it renamed PolyNovo in 2014 and was incorporated in 1998.
Company score
- Sentiment
- 0.36
- SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
- Environment
- 0.00
- EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
- Social
- 0.36
- Governance
- 0.00
- GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
- Sustainability
- 0.11
- SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
- Impact Score
- 0.23
- Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive
Loading section